Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases - PubMed (original) (raw)
Affiliations
- PMID: 9219791
Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases
D Heresbach et al. Am J Gastroenterol. 1997 Jul.
Abstract
Objective: Genetic susceptibility to inflammatory bowel disease is well recognized. There is also increasing evidence for the activation of the mucosal immune system and the production of inflammatory cytokines, i.e., interleukin (IL)-1ra and IL-1beta in the inflammatory bowel disease. The aim of this study was to analyze the IL-1beta and IL-1ra gene polymorphism and linkage disequilibrium coefficient between the different alleles of these genes in patients with Crohn's disease (CD) or ulcerative colitis (UC), according to the severity of the disease.
Methods: Two hundred twenty-eight inflammatory bowel disease patients (87 UC and 141 CD) were included in this study and compared with 113 unrelated controls. The IL-1beta and IL-1ra gene polymorphism was studied after specific amplification of variable regions by PCR. A penta-allelic polymorphism, corresponding to a VNTR region located in intron 2 of the IL-1ra gene, was analyzed, whereas bi-allelic RFLPs displayed by two restriction enzymes (TaqI and AvaI) at position -511 of the IL-1beta gene were analyzed.
Results: There was no significant difference of genotype distribution between controls and CD or UC patients. However, surgically treated UC patients were characterized by a higher frequency of genotype IL-1ra 1-2 (39 vs 16%, pc < 0.01) compared with nonoperated UC patients. Moreover, nonoperated UC patients displayed a lower frequency of IL-1ra allele 2 than surgically treated UC patients (14 vs 34%, pc < 0.002) or controls (14 vs 30%, pc < 0.005). Furthermore, simultaneous analysis of the IL-1beta and IL-1ra genes that are located in the same region of chromosome 2 revealed that CD patients carrying the IL-1beta allele 2 were more often noncarriers of IL-1ra allele 2 (p < 0.005). Moreover, UC and CD patients were, characterized by a lower frequency of the association of IL-1ra allele 2 and IL-1beta allele 2 compared with controls (8.3 vs 20.3% and 10.6 vs 20.3%, p < 0.03).
Conclusions: IL-1ra and IL-1beta gene polymorphism analysis from a clinical standpoint might help in defining UC prognosis. However, functional studies at both the circulating and mucosal level with stratification on allele associations, especially IL-1ra allele 2-IL-1beta allele 2 subgroups must be realized before therapeutic implications.
Similar articles
- IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD, Bid HK, Ghoshal UC. Mittal RD, et al. Scand J Gastroenterol. 2005 Jul;40(7):827-31. doi: 10.1080/00365520510015629. Scand J Gastroenterol. 2005. PMID: 16109659 - Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Peña AS. Bioque G, et al. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):105-10. Eur J Gastroenterol Hepatol. 1996. PMID: 8723412 - Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
Celik Y, Dagli U, Kiliç MY, Törüner M, Ozen SC, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM. Celik Y, et al. Scand J Gastroenterol. 2006 May;41(5):559-65. doi: 10.1080/00365520500349523. Scand J Gastroenterol. 2006. PMID: 16638698 - Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease.
Yang H. Yang H. Exp Clin Immunogenet. 1997;14(3):214-25. Exp Clin Immunogenet. 1997. PMID: 9493790 Review. - IL-10 and IL-10 receptor defects in humans.
Glocker EO, Kotlarz D, Klein C, Shah N, Grimbacher B. Glocker EO, et al. Ann N Y Acad Sci. 2011 Dec;1246:102-7. doi: 10.1111/j.1749-6632.2011.06339.x. Ann N Y Acad Sci. 2011. PMID: 22236434 Review.
Cited by
- Polymorphisms of the IL-1beta and IL-1beta-inducible genes in ulcerative colitis.
Nohara H, Saito Y, Higaki S, Okayama N, Hamanaka Y, Okita K, Hinoda Y. Nohara H, et al. J Gastroenterol. 2002 Nov;37 Suppl 14:107-10. doi: 10.1007/BF03326427. J Gastroenterol. 2002. PMID: 12572877 - Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Stokkers PC, et al. Gut. 1998 Jul;43(1):33-9. doi: 10.1136/gut.43.1.33. Gut. 1998. PMID: 9771403 Free PMC article. - Defective interleukin-1 receptor antagonist production is associated with resistance of acute liver graft rejection to steroid therapy.
Conti F, Breton S, Batteux F, Furlan V, Houssin D, Weill B, Calmus Y. Conti F, et al. Am J Pathol. 2000 Nov;157(5):1685-92. doi: 10.1016/S0002-9440(10)64805-5. Am J Pathol. 2000. PMID: 11073827 Free PMC article. - IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway.
Al-Sadi R, Ye D, Said HM, Ma TY. Al-Sadi R, et al. Am J Pathol. 2010 Nov;177(5):2310-22. doi: 10.2353/ajpath.2010.100371. Am J Pathol. 2010. PMID: 21048223 Free PMC article. - Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk.
He Y, Liang X, Meng C, Shao Z, Gao Y, Wu Q, Liu J, Wang H, Yang S. He Y, et al. Int Orthop. 2014 Aug;38(8):1671-6. doi: 10.1007/s00264-014-2374-2. Epub 2014 May 31. Int Orthop. 2014. PMID: 24878968 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources